Yayın: Pharmacokinetics, Tissue Residues, and Withdrawal Times of Oxytetracycline in Rainbow Trout (Oncorhynchus mykiss) after Single- and Multiple-Dose Oral Administration
| dc.contributor.author | Corum, Orhan | |
| dc.contributor.author | Durna Corum, Duygu | |
| dc.contributor.author | Terzi, Ertugrul | |
| dc.contributor.author | Uney, Kamil | |
| dc.date.accessioned | 2026-01-04T19:34:45Z | |
| dc.date.issued | 2023-12-14 | |
| dc.description.abstract | The aim of this study was to compare the pharmacokinetics of oxytetracycline (OTC) following single- (60 mg/kg) and multiple-dose oral administrations (60 mg/kg, every 24 h for 7 days) in rainbow trout. It also aimed to determine bioavailability after a single dose and tissue residues and withdrawal times after multiple doses. This study was carried out on 420 rainbow trout at 9 ± 0.8 °C. This study was carried out in two stages: single-dose (intravascular and oral) and multiple-dose treatment. The OTC concentrations in plasma and tissues were measured by high-performance liquid chromatography and analyzed by a non-compartmental method. The withdrawal time (WT) was estimated using the WT 1.4 software. OTC exhibited a long terminal elimination half-life (t1/2ʎz) after IV and oral administration. The oral bioavailability of OTC was very low (2.80%). In multiple-dose treatment, t1/2ʎz, the area under the plasma concentration–time curve and peak plasma concentration increased significantly after the last day compared to the first day. OTC showed strong accumulation after multiple doses with a value of 5.33. OTC concentrations were obtained in the order liver > kidney > muscle+skin > plasma. At 9 ± 0.8 °C, the WT calculated for muscle+skin was 56 days for Europe and 50 days for China, respectively. The t1/2ʎz (68.94 h) and time (68 h) above the 1 µg/mL MIC following a single OTC dose may support the extension of the 24 h dosing interval following multiple dosing. However, further studies are required to determine the optimal dosage regimen in multiple-dose OTC treatment in the treatment of infections caused by susceptible pathogens. | |
| dc.description.uri | https://doi.org/10.3390/ani13243845 | |
| dc.description.uri | https://pubmed.ncbi.nlm.nih.gov/38136882 | |
| dc.description.uri | http://dx.doi.org/10.3390/ani13243845 | |
| dc.description.uri | https://doaj.org/article/c1bd9da9e6044e5689fccef50c1f041c | |
| dc.description.uri | https://hdl.handle.net/20.500.12483/7764 | |
| dc.identifier.doi | 10.3390/ani13243845 | |
| dc.identifier.eissn | 2076-2615 | |
| dc.identifier.openaire | doi_dedup___::df7c15a2a51ad68e219e75881c2277eb | |
| dc.identifier.orcid | 0000-0003-3168-2510 | |
| dc.identifier.orcid | 0000-0003-2811-6497 | |
| dc.identifier.orcid | 0000-0002-8674-4873 | |
| dc.identifier.pubmed | 38136882 | |
| dc.identifier.scopus | 2-s2.0-85180488642 | |
| dc.identifier.startpage | 3845 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12597/41286 | |
| dc.identifier.volume | 13 | |
| dc.identifier.wos | 001135931500001 | |
| dc.language.iso | eng | |
| dc.publisher | MDPI AG | |
| dc.relation.ispartof | Animals | |
| dc.rights | OPEN | |
| dc.subject | food safety | |
| dc.subject | aquaculture | |
| dc.subject | QL1-991 | |
| dc.subject | Veterinary medicine | |
| dc.subject | public health | |
| dc.subject | SF600-1100 | |
| dc.subject | drug residue | |
| dc.subject | Zoology | |
| dc.subject | antibiotics | |
| dc.subject | Article | |
| dc.subject.sdg | 3. Good health | |
| dc.title | Pharmacokinetics, Tissue Residues, and Withdrawal Times of Oxytetracycline in Rainbow Trout (Oncorhynchus mykiss) after Single- and Multiple-Dose Oral Administration | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.api.response | {"authors":[{"fullName":"Orhan Corum","name":"Orhan","surname":"Corum","rank":1,"pid":{"id":{"scheme":"orcid","value":"0000-0003-3168-2510"},"provenance":null}},{"fullName":"Duygu Durna Corum","name":"Duygu","surname":"Durna Corum","rank":2,"pid":null},{"fullName":"Ertugrul Terzi","name":"Ertugrul","surname":"Terzi","rank":3,"pid":{"id":{"scheme":"orcid","value":"0000-0003-2811-6497"},"provenance":null}},{"fullName":"Kamil Uney","name":"Kamil","surname":"Uney","rank":4,"pid":{"id":{"scheme":"orcid","value":"0000-0002-8674-4873"},"provenance":null}}],"openAccessColor":"gold","publiclyFunded":false,"type":"publication","language":{"code":"eng","label":"English"},"countries":null,"subjects":[{"subject":{"scheme":"keyword","value":"food safety"},"provenance":null},{"subject":{"scheme":"keyword","value":"aquaculture"},"provenance":null},{"subject":{"scheme":"keyword","value":"QL1-991"},"provenance":null},{"subject":{"scheme":"keyword","value":"Veterinary medicine"},"provenance":null},{"subject":{"scheme":"keyword","value":"public health"},"provenance":null},{"subject":{"scheme":"keyword","value":"SF600-1100"},"provenance":null},{"subject":{"scheme":"keyword","value":"drug residue"},"provenance":null},{"subject":{"scheme":"keyword","value":"Zoology"},"provenance":null},{"subject":{"scheme":"keyword","value":"antibiotics"},"provenance":null},{"subject":{"scheme":"keyword","value":"Article"},"provenance":null},{"subject":{"scheme":"SDG","value":"3. Good health"},"provenance":null}],"mainTitle":"Pharmacokinetics, Tissue Residues, and Withdrawal Times of Oxytetracycline in Rainbow Trout (Oncorhynchus mykiss) after Single- and Multiple-Dose Oral Administration","subTitle":null,"descriptions":["<jats:p>The aim of this study was to compare the pharmacokinetics of oxytetracycline (OTC) following single- (60 mg/kg) and multiple-dose oral administrations (60 mg/kg, every 24 h for 7 days) in rainbow trout. It also aimed to determine bioavailability after a single dose and tissue residues and withdrawal times after multiple doses. This study was carried out on 420 rainbow trout at 9 ± 0.8 °C. This study was carried out in two stages: single-dose (intravascular and oral) and multiple-dose treatment. The OTC concentrations in plasma and tissues were measured by high-performance liquid chromatography and analyzed by a non-compartmental method. The withdrawal time (WT) was estimated using the WT 1.4 software. OTC exhibited a long terminal elimination half-life (t1/2ʎz) after IV and oral administration. The oral bioavailability of OTC was very low (2.80%). In multiple-dose treatment, t1/2ʎz, the area under the plasma concentration–time curve and peak plasma concentration increased significantly after the last day compared to the first day. OTC showed strong accumulation after multiple doses with a value of 5.33. OTC concentrations were obtained in the order liver > kidney > muscle+skin > plasma. At 9 ± 0.8 °C, the WT calculated for muscle+skin was 56 days for Europe and 50 days for China, respectively. The t1/2ʎz (68.94 h) and time (68 h) above the 1 µg/mL MIC following a single OTC dose may support the extension of the 24 h dosing interval following multiple dosing. However, further studies are required to determine the optimal dosage regimen in multiple-dose OTC treatment in the treatment of infections caused by susceptible pathogens.</jats:p>"],"publicationDate":"2023-12-14","publisher":"MDPI AG","embargoEndDate":null,"sources":["Crossref","Animals (Basel)","Animals, Vol 13, Iss 24, p 3845 (2023)"],"formats":["application/pdf"],"contributors":null,"coverages":null,"bestAccessRight":{"code":"c_abf2","label":"OPEN","scheme":"http://vocabularies.coar-repositories.org/documentation/access_rights/"},"container":{"name":"Animals","issnPrinted":null,"issnOnline":"2076-2615","issnLinking":null,"ep":null,"iss":null,"sp":"3845","vol":"13","edition":null,"conferencePlace":null,"conferenceDate":null},"documentationUrls":null,"codeRepositoryUrl":null,"programmingLanguage":null,"contactPeople":null,"contactGroups":null,"tools":null,"size":null,"version":null,"geoLocations":null,"id":"doi_dedup___::df7c15a2a51ad68e219e75881c2277eb","originalIds":["ani13243845","10.3390/ani13243845","50|doiboost____|df7c15a2a51ad68e219e75881c2277eb","od_______267::352e2fa5bb38351c3d987bc85fef2afd","38136882","PMC10740422","oai:pubmedcentral.nih.gov:10740422","50|od_______267::352e2fa5bb38351c3d987bc85fef2afd","50|doajarticles::26b3fbc3999616ea6d7b61601180c31a","oai:doaj.org/article:c1bd9da9e6044e5689fccef50c1f041c","50|od______4778::2f3a250f1ba758c4d9fd74156aa32f02","oai:openaccess.mku.edu.tr:20.500.12483/7764"],"pids":[{"scheme":"doi","value":"10.3390/ani13243845"},{"scheme":"pmid","value":"38136882"},{"scheme":"pmc","value":"PMC10740422"},{"scheme":"handle","value":"20.500.12483/7764"}],"dateOfCollection":null,"lastUpdateTimeStamp":null,"indicators":{"citationImpact":{"citationCount":10,"influence":2.9512688e-9,"popularity":9.12247e-9,"impulse":10,"citationClass":"C5","influenceClass":"C5","impulseClass":"C4","popularityClass":"C4"}},"instances":[{"pids":[{"scheme":"doi","value":"10.3390/ani13243845"}],"license":"CC BY","type":"Article","urls":["https://doi.org/10.3390/ani13243845"],"publicationDate":"2023-12-14","refereed":"peerReviewed"},{"pids":[{"scheme":"pmid","value":"38136882"},{"scheme":"pmc","value":"PMC10740422"}],"alternateIdentifiers":[{"scheme":"doi","value":"10.3390/ani13243845"}],"type":"Article","urls":["https://pubmed.ncbi.nlm.nih.gov/38136882"],"refereed":"nonPeerReviewed"},{"alternateIdentifiers":[{"scheme":"doi","value":"10.3390/ani13243845"}],"license":"CC BY","type":"Other literature type","urls":["http://dx.doi.org/10.3390/ani13243845"],"publicationDate":"2023-12-14","refereed":"nonPeerReviewed"},{"alternateIdentifiers":[{"scheme":"doi","value":"10.3390/ani13243845"}],"type":"Article","urls":["https://doaj.org/article/c1bd9da9e6044e5689fccef50c1f041c"],"publicationDate":"2023-12-01","refereed":"nonPeerReviewed"},{"pids":[{"scheme":"handle","value":"20.500.12483/7764"}],"alternateIdentifiers":[{"scheme":"doi","value":"10.3390/ani13243845"}],"type":"Article","urls":["https://doi.org/10.3390/ani13243845","https://hdl.handle.net/20.500.12483/7764"],"publicationDate":"2024-09-18","refereed":"nonPeerReviewed"}],"isGreen":true,"isInDiamondJournal":false} | |
| local.import.source | OpenAire | |
| local.indexed.at | WOS | |
| local.indexed.at | Scopus | |
| local.indexed.at | PubMed |
